Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KANTR (KDM5C adjacent non-coding transcript) is annotated as a long non-coding RNA gene located on the X chromosome, adjacent to KDM5C. It is sometimes incorrectly referred to as an "integral membrane protein," but available evidence indicates KANTR does not encode a characterized protein product. Instead, it functions primarily as a non-coding transcript, with mutations in its locus in mice causing tremors and spastic movements, suggesting a potential role in neurological development or function. There is no evidence that KANTR is a classical therapeutic target, receptor, enzyme, transporter, or signaling protein[1][6][10][8]. Current gene and protein databases do not list it as a functional membrane protein, and there are no known drug modulators or clear biological mechanisms attributed to its non-coding transcript. Caution: Referencing "KANTR integral membrane protein" as a protein-coding receptor or drug target is misleading and not scientifically supported by current gene/protein annotation resources[1][10][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KDM5C adjacent non-coding transcript (KANTR).